Stock Performance Spotlight: MaxCyte Inc (MXCT) Ends the Day at 3.94, Down by -1.25

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

As of close of business last night, MaxCyte Inc’s stock clocked out at $3.94, down -1.25% from its previous closing price of $3.99. In other words, the price has decreased by -$1.25 from its previous closing price. On the day, 0.83 million shares were traded. MXCT stock price reached its highest trading level at $4.005 during the session, while it also had its lowest trading level at $3.875.

Ratios:

To gain a deeper understanding of MXCT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.97 and its Current Ratio is at 10.65. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.08.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on November 29, 2023, initiated with a Buy rating and assigned the stock a target price of $7.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 26 ’24 when Johnston John Joseph sold 5,000 shares for $4.41 per share. The transaction valued at 22,025 led to the insider holds 120,583 shares of the business.

Johnston John Joseph sold 5,000 shares of MXCT for $25,585 on Jan 26 ’24. The Director now owns 120,583 shares after completing the transaction at $5.12 per share. On Dec 26 ’23, another insider, Johnston John Joseph, who serves as the Director of the company, sold 5,000 shares for $4.53 each. As a result, the insider received 22,650 and left with 120,583 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MXCT now has a Market Capitalization of 410323424 and an Enterprise Value of 260721888. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.94 while its Price-to-Book (P/B) ratio in mrq is 1.76. Its current Enterprise Value per Revenue stands at 6.315 whereas that against EBITDA is -5.908.

Stock Price History:

Over the past 52 weeks, MXCT has reached a high of $5.55, while it has fallen to a 52-week low of $2.45. The 50-Day Moving Average of the stock is -10.19%, while the 200-Day Moving Average is calculated to be -6.04%.

Shares Statistics:

It appears that MXCT traded 589.29K shares on average per day over the past three months and 434040 shares per day over the past ten days. A total of 103.96M shares are outstanding, with a floating share count of 91.41M. Insiders hold about 12.22% of the company’s shares, while institutions hold 71.03% stake in the company. Shares short for MXCT as of 1711584000 were 3257355 with a Short Ratio of 5.53, compared to 1709164800 on 3104515. Therefore, it implies a Short% of Shares Outstanding of 3257355 and a Short% of Float of 3.17.

Earnings Estimates

The dynamic stock of MaxCyte Inc (MXCT) is currently attracting attention from Mexco Energy Corporation analysts actively involved in rating its market status.

Most Popular

[the_ad id="945"]